# | Title | Journal | Year | Citations |
---|
1 | Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel | European Heart Journal | 2017 | 2,292 |
2 | Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA Trial | Journal of the American College of Cardiology | 2007 | 752 |
3 | Aspirin resistance | Lancet, The | 2006 | 503 |
4 | Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance | Journal of the American College of Cardiology | 2014 | 465 |
5 | Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial | Phytotherapy Research | 2016 | 316 |
6 | Aspirin resistance: position paper of the Working Group on Aspirin Resistance | Journal of Thrombosis and Haemostasis | 2005 | 315 |
7 | Improved outcomes and reduced costs associated with a health‐system–wide patient blood management program: a retrospective observational study in four major adult tertiary‐care hospitals | Transfusion | 2017 | 289 |
8 | Medical Treatment of Peripheral Arterial Disease | JAMA - Journal of the American Medical Association | 2006 | 285 |
9 | Predicting Cardiovascular Events in Familial Hypercholesterolemia | Circulation | 2017 | 270 |
10 | A procedure‐specific systematic review and consensus recommendations for postoperative analgesia following total knee arthroplasty | Anaesthesia | 2008 | 262 |
11 | The role of ketamine in pain management | Biomedicine and Pharmacotherapy | 2006 | 226 |
12 | Effects of curcumin on serum cytokine concentrations in subjects with metabolic syndrome: A post-hoc analysis of a randomized controlled trial | Biomedicine and Pharmacotherapy | 2016 | 221 |
13 | Melissa officinalis L. – A review of its traditional uses, phytochemistry and pharmacology | Journal of Ethnopharmacology | 2016 | 221 |
14 | Efficacy and Safety of Phytosomal Curcumin in Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial | Drug Research | 2017 | 217 |
15 | Lipid-modifying effects of adjunctive therapy with curcuminoids–piperine combination in patients with metabolic syndrome: Results of a randomized controlled trial | Complementary Therapies in Medicine | 2014 | 207 |
16 | Alirocumab as Add-On to Atorvastatin Versus Other Lipid Treatment Strategies: ODYSSEY OPTIONS I Randomized Trial | Journal of Clinical Endocrinology and Metabolism | 2015 | 198 |
17 | Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study | Lancet Diabetes and Endocrinology,the | 2017 | 191 |
18 | Familial hypercholesterolaemia: A model of care for Australasia | Atherosclerosis Supplements | 2011 | 181 |
19 | Cardiometabolic risk factors in people with psychotic disorders: The second Australian national survey of psychosis | Australian and New Zealand Journal of Psychiatry | 2012 | 166 |
20 | Omega-3 Fatty Acid Supplementation Decreases Liver Fat Content in Polycystic Ovary Syndrome: A Randomized Controlled Trial Employing Proton Magnetic Resonance Spectroscopy | Journal of Clinical Endocrinology and Metabolism | 2009 | 164 |
21 | Conservative versus Interventional Treatment for Spontaneous Pneumothorax | New England Journal of Medicine | 2020 | 164 |
22 | Factors associated with suicidal thoughts in a large community study of older adults | British Journal of Psychiatry | 2012 | 158 |
23 | Cascade screening based on genetic testing is cost-effective: Evidence for the implementation of models of care for familial hypercholesterolemia | Journal of Clinical Lipidology | 2014 | 149 |
24 | Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above | Circulation | 2017 | 144 |
25 | Promoting Global Research Excellence in Severe Sepsis (PROGRESS): Lessons from an International Sepsis Registry | Infection | 2009 | 139 |
26 | Statin therapy reduces plasma endothelin-1 concentrations: A meta-analysis of 15 randomized controlled trials | Atherosclerosis | 2015 | 139 |
27 | Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study | BMJ: British Medical Journal | 2010 | 136 |
28 | Delayed Administration of Antibiotics and Atypical Presentation in Community-Acquired Pneumonia | Chest | 2006 | 135 |
29 | New LDL-Cholesterol Lowering Therapies: Pharmacology, Clinical Trials, and Relevance to Acute Coronary Syndromes | Clinical Therapeutics | 2013 | 134 |
30 | New Therapies Targeting apoB Metabolism for High-Risk Patients with Inherited Dyslipidaemias: What Can the Clinician Expect? | Cardiovascular Drugs and Therapy | 2013 | 133 |
31 | Effect of statin therapy on paraoxonase-1 status: A systematic review and meta-analysis of 25 clinical trials | Progress in Lipid Research | 2015 | 133 |
32 | Investigation of the Efficacy of Adjunctive Therapy with Bioavailability‐Boosted Curcuminoids in Major Depressive Disorder | Phytotherapy Research | 2015 | 128 |
33 | The effect of yoghurt and its probiotics on blood pressure and serum lipid profile; a randomised controlled trial | Nutrition, Metabolism and Cardiovascular Diseases | 2015 | 123 |
34 | The cardiovascular health benefits of apples: Whole fruit vs. isolated compounds | Trends in Food Science and Technology | 2017 | 123 |
35 | Short-term Curcuminoid Supplementation for Chronic Pulmonary Complications due to Sulfur Mustard Intoxication: Positive Results of a Randomized Double-blind Placebo-controlled Trial | Drug Research | 2015 | 119 |
36 | Effect of Alirocumab on Lipoprotein(a) Over ≥1.5 Years (from the Phase 3 ODYSSEY Program) | American Journal of Cardiology | 2017 | 116 |
37 | Non-adherence to statin therapy: a major challenge for preventive cardiology | Expert Opinion on Pharmacotherapy | 2009 | 114 |
38 | Perinatal and childhood origins of cardiovascular disease | International Journal of Obesity | 2007 | 110 |
39 | Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) study | American Heart Journal | 2009 | 106 |
40 | Antifungal Therapy and Management of Complications of Cryptococcosis due to Cryptococcus gattii | Clinical Infectious Diseases | 2013 | 106 |
41 | Toward an international consensus—Integrating lipoprotein apheresis and new lipid-lowering drugs | Journal of Clinical Lipidology | 2017 | 105 |
42 | Quality use of medicines and health outcomes among a cohort of community dwelling older men: an observational study | British Journal of Clinical Pharmacology | 2011 | 101 |
43 | Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation | Journal of Clinical Lipidology | 2014 | 98 |
44 | Update on the role of non-opioids for postoperative pain treatment | Bailliere's Best Practice and Research in Clinical Anaesthesiology | 2007 | 97 |
45 | Effect of monoclonal antibodies to PCSK9 on high‐sensitivity C‐reactive protein levels: a meta‐analysis of 16 randomized controlled treatment arms | British Journal of Clinical Pharmacology | 2016 | 96 |
46 | The effects of a nutraceutical combination on plasma lipids and glucose: A systematic review and meta -analysis of randomized controlled trials | Pharmacological Research | 2016 | 94 |
47 | Successful Mental Health Aging: Results From a Longitudinal Study of Older Australian Men | American Journal of Geriatric Psychiatry | 2006 | 93 |
48 | HDL is the major lipoprotein carrier of plasma F2-isoprostanes | Journal of Lipid Research | 2009 | 93 |
49 | Dreaming during Anesthesia and Anesthetic Depth in Elective Surgery Patients | Anesthesiology | 2007 | 92 |
50 | Lifecourse Childhood Adiposity Trajectories Associated With Adolescent Insulin Resistance | Diabetes Care | 2011 | 92 |